C Charman

Summary

Affiliation: University of Nottingham
Country: UK

Publications

  1. ncbi request reprint Topical corticosteroid phobia in patients with atopic eczema
    C R Charman
    Department of Dermatology, Queen s Medical Centre, Nottingham NG7 2UH, U K
    Br J Dermatol 142:931-6. 2000
  2. ncbi request reprint Outcome measures of disease severity in atopic eczema
    C Charman
    Department of Dermatology, Queen s Medical Centre, Nottingham, England
    Arch Dermatol 136:763-9. 2000
  3. ncbi request reprint Reliability testing of the Six Area, Six Sign Atopic Dermatitis severity score
    C R Charman
    Department of Dermatology, Queen s Medical Centre, Nottingham NG7 2UH, UK
    Br J Dermatol 146:1057-60. 2002
  4. ncbi request reprint The use of corticosteroids and corticosteroid phobia in atopic dermatitis
    Carolyn Charman
    Department of Dermatology, Queen s Medical Centre, Nottingham, United Kingdom
    Clin Dermatol 21:193-200. 2003
  5. ncbi request reprint Measuring atopic dermatitis severity in randomized controlled clinical trials: what exactly are we measuring?
    Carolyn Charman
    Center of Evidence Based Dermatology, Queen s Medical Center, University Hospital, Nottingham, UK
    J Invest Dermatol 120:932-41. 2003
  6. ncbi request reprint The patient-oriented eczema measure: development and initial validation of a new tool for measuring atopic eczema severity from the patients' perspective
    Carolyn R Charman
    Department of Dermatology, Queen s Medical Centre, Nottingham, England
    Arch Dermatol 140:1513-9. 2004
  7. ncbi request reprint Measuring atopic eczema severity visually: which variables are most important to patients?
    Carolyn R Charman
    Department of Dermatology, Queen s Medical Centre, University Hospital, Nottingham NG7 2UH, England, UK
    Arch Dermatol 141:1146-51; discussion 1151. 2005
  8. ncbi request reprint The Nottingham Eczema Severity Score: preliminary refinement of the Rajka and Langeland grading
    R M Emerson
    Dermato Epidemiology Research Unit, University Hospital, Queen s Medical Centre, Nottingham, UK
    Br J Dermatol 142:288-97. 2000

Detail Information

Publications8

  1. ncbi request reprint Topical corticosteroid phobia in patients with atopic eczema
    C R Charman
    Department of Dermatology, Queen s Medical Centre, Nottingham NG7 2UH, U K
    Br J Dermatol 142:931-6. 2000
    ..This study highlights the need for provision of better information and education to patients and possibly general practitioners regarding the safety, potency and appropriate use of topical corticosteroids...
  2. ncbi request reprint Outcome measures of disease severity in atopic eczema
    C Charman
    Department of Dermatology, Queen s Medical Centre, Nottingham, England
    Arch Dermatol 136:763-9. 2000
    ..An essential component of evidence-based medicine is the use of valid and reliable outcome measures in clinical trials. There is much confusion in the field of atopic eczema regarding how to best measure disease severity objectively...
  3. ncbi request reprint Reliability testing of the Six Area, Six Sign Atopic Dermatitis severity score
    C R Charman
    Department of Dermatology, Queen s Medical Centre, Nottingham NG7 2UH, UK
    Br J Dermatol 146:1057-60. 2002
    ..Validity has been demonstrated in single and multicentre clinical trials, although data on the reliability of the index have not previously been published...
  4. ncbi request reprint The use of corticosteroids and corticosteroid phobia in atopic dermatitis
    Carolyn Charman
    Department of Dermatology, Queen s Medical Centre, Nottingham, United Kingdom
    Clin Dermatol 21:193-200. 2003
  5. ncbi request reprint Measuring atopic dermatitis severity in randomized controlled clinical trials: what exactly are we measuring?
    Carolyn Charman
    Center of Evidence Based Dermatology, Queen s Medical Center, University Hospital, Nottingham, UK
    J Invest Dermatol 120:932-41. 2003
    ..More emphasis should be placed on measuring things that are important to patients such as symptoms and quality of life...
  6. ncbi request reprint The patient-oriented eczema measure: development and initial validation of a new tool for measuring atopic eczema severity from the patients' perspective
    Carolyn R Charman
    Department of Dermatology, Queen s Medical Centre, Nottingham, England
    Arch Dermatol 140:1513-9. 2004
    ..To develop a simple, valid, repeatable, and readily understandable patient-oriented assessment measure for monitoring disease activity in children and adults with atopic eczema...
  7. ncbi request reprint Measuring atopic eczema severity visually: which variables are most important to patients?
    Carolyn R Charman
    Department of Dermatology, Queen s Medical Centre, University Hospital, Nottingham NG7 2UH, England, UK
    Arch Dermatol 141:1146-51; discussion 1151. 2005
    ..There is wide variation in the objective visual variables used to measure atopic eczema severity in clinical trials, making comparison and interpretation of results difficult...
  8. ncbi request reprint The Nottingham Eczema Severity Score: preliminary refinement of the Rajka and Langeland grading
    R M Emerson
    Dermato Epidemiology Research Unit, University Hospital, Queen s Medical Centre, Nottingham, UK
    Br J Dermatol 142:288-97. 2000
    ..Further validation is required with respect to use in older children, administration by researchers/health professionals and development as a wholly questionnaire-based assessment...